View PowerPoint Presentation - Vision Research Coordinating Center

More documents

Recommendations

Info

Proportion POAG1 st Optic Disc POAG Endpoint*Log Rank P-value
First POAG Endpoint per ParticipantMedicationObservationN % N %Visual Field 15 41.7 29 32.6Optic Disc 18 50.0 51 57.3Concurrent VisualField and Optic Disc3 8.3 9 10.1Total 36 100 89 100June, 2002
Page 1 and 2: The Ocular HypertensionTreatment St
Page 3 and 4: Why did we do this study?Don’t we
Page 5 and 6: Ocular Hypertension Treatment Study
Page 7 and 8: Patient found eligible for OHTS•
Page 9 and 10: Baseline Characteristics by Randomi
Page 15 and 16: IOP By RaceMedicationObservationAfr
Page 17 and 18: Progress and Outcome of Study Parti
Page 19: Proportion POAG1 st Visual Field PO
Page 23 and 24: Treatment perhaps less protectivein
Page 25 and 26: Percent Reporting Changes inIris, L
Page 27 and 28: Borderline Safety DifferencesBetwee
Page 29 and 30: Significant Baseline Predictive Fac
Page 31 and 32: Significant Baseline Predictive Fac
Page 33 and 34: POAG Endpoints by Central Corneal T
Page 35 and 36: 60-year-old WF IOP 24 / 24 C/D rati
Page 37 and 38: 60-year-old WF IOP 28 / 28 C/D rati
Page 39 and 40: 72-year-old BM IOP 25 / 25 C/D rati
Page 41 and 42: Weaknesses1. Convenience sample rat
Page 43 and 44: Possible Misinterpretations of OHTS
Page 45: OHTS Clinical CentersBascom Palmer

View PowerPoint Presentation - Vision Research Coordinating Center

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?